The Back the Blue Act of 2025 creates new federal criminal offenses for killing or assaulting law enforcement officers, judges, and certain public safety personnel (including firefighters and first responders) while they are on duty or because of their official status. It increases penalties for these crimes, including minimum 10-year prison terms for killing officers and longer sentences for assaults causing serious injury, with the death penalty possible for killings. The bill also adds a "flight to avoid prosecution" provision for those fleeing to evade charges for killing officers, expands law enforcement officers' rights to carry firearms in certain circumstances, and limits federal habeas corpus relief for individuals convicted of killing law enforcement officers. This legislation directly affects law enforcement officers, judges, and public safety personnel, as well as individuals who commit violence against them.
HR 6466, the Forced Abortion Prevention and Accountability Act, prohibits non-consensual administration of abortion drugs (like mifepristone or misoprostol) to pregnant women without their informed consent. It criminalizes this act with penalties up to 25 years in prison and allows victims to sue for triple damages, psychological/physical injury compensation, and attorney fees. The bill directly affects pregnant women who might face coerced procedures and medical providers or others who administer such drugs without consent. Key provisions include criminal penalties for the act itself, enhanced penalties for serious injury or death, and a civil remedy framework for victims seeking compensation.
This bill amends federal pay rules to expand higher overtime pay rates for U.S. Border Patrol supervisors. It changes the eligibility from only GS-12 agents to include all supervisors classified from GS-12 through GS-15. The key provision modifies Section 5550(h) of Title 5, U.S. Code, to apply the higher overtime pay rate to these higher-grade supervisory positions. The bill aims to improve retention for experienced Border Patrol supervisors by increasing their overtime compensation.
The Dignity for Detained Immigrants Act establishes minimum standards for detention facilities operated by the Department of Homeland Security, requiring them to follow the American Bar Association's Civil Immigration Detention Standards. It mandates annual unannounced inspections by the DHS Inspector General, with penalties including fines for noncompliant private facilities and transfers of detainees from noncompliant facilities. The bill requires DHS to publicly report on facility compliance, phase out private detention facilities over three years, and prohibit solitary confinement. It also ensures detainees have access to legal orientation, counsel, and more frequent custody review hearings. The bill directly affects all individuals detained in DHS custody, including immigrants, asylum seekers, and refugees held in facilities operated by or contracted to DHS.
This bill increases the tax exclusion for capital gains when selling a primary residence. It doubles the exclusion amount from $250,000 (for single filers) to $500,000 and from $500,000 (for married couples) to $1,000,000. The bill also adds an inflation adjustment for amounts after 2025, tying future increases to the cost-of-living adjustment. It directly affects homeowners who sell their primary residence and would otherwise owe tax on profits exceeding the previous limits. The changes apply to sales after the bill's enactment date.
HR 6372, the D.C. Shield Law Repeal Act, repeals the Human Rights Sanctuary Amendment Act of 2022 (D.C. Law 24-257), which had modified District of Columbia protections for certain immigrant residents. The bill restores the previous legal framework that existed before the 2022 amendment took effect. This directly affects D.C. law and its implementation regarding immigrant rights within the District.
The Medical Foods and Formulas Access Act of 2025 would require Medicare, Medicaid, CHIP, and the Federal Employees Health Benefits Program to cover medically necessary food for people with specific digestive and metabolic disorders. This includes specialized formulas and nutrients prescribed by healthcare providers for conditions like inherited metabolic disorders, inflammatory bowel disease, and food protein allergies. The bill defines "medically necessary food" to include items such as amino acid preparations, low protein modified foods, and vitamins specifically designed for these conditions, along with necessary medical equipment for administration. Coverage would apply to federal health programs with different effective dates (1-3 years from enactment) and encourages private health insurance plans to provide similar coverage for these life-sustaining treatments.
The Artificial Intelligence Civil Rights Act of 2025 requires developers and deployers of AI systems that make decisions affecting "consequential actions" (such as employment, housing, healthcare, education, and credit) to conduct pre-deployment evaluations and annual impact assessments by independent auditors. The bill mandates transparency requirements including clear disclosures to individuals about how AI is used in decision-making, establishes a right to human alternatives for significant AI-driven decisions, and prohibits discrimination based on protected characteristics like race, gender, or disability. It creates enforcement mechanisms through the Federal Trade Commission, state attorneys general, and private lawsuits, with penalties including civil penalties of up to 4% of annual revenue. The act also requires developers to provide explanations for AI-driven decisions and sets standards for data collection to prevent harm and ensure fairness in critical life areas.
This bill suspends payment limits for agricultural subsidies for the 2025 crop year, removing caps on payments to farmers. It also establishes a new option for farmers to receive 50% of their expected 2025 crop payments as an advance by December 1, 2025, if they opt in. The remaining balance is paid later after the marketing year ends, with farmers required to repay any overpayment if the final amount exceeds the advance. The bill directly affects farmers growing covered commodities (like corn, soybeans) who choose to participate in the advance payment program.
This bill creates federal grants to help community colleges expand agriculture and natural resources programs. It provides competitive funding to community colleges and college consortia to support workforce training, education, research, and outreach - especially when partnering with local agriculture businesses. Funds can be used for equipment, faculty development, apprenticeships, and programming on farm business management topics like accounting and finance. The bill authorizes $20 million annually from 2026-2031, requiring a 3-year evaluation report to Congress on program impacts.
Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research. Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research. The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)
The ADOPT Act of 2025 creates federal criminal penalties for unlicensed individuals or entities providing adoption intermediary services (like connecting birth parents with adoptive parents for profit) or placing paid "adoption advertisements" that solicit parties for placement. It prohibits payments exceeding $2,500 to birth parents before consulting a licensed agency or attorney, aiming to prevent exploitation and the commodification of children in private domestic adoptions. The law directly affects unlicensed intermediaries and commercial facilitators, while exempting licensed adoption agencies, attorneys, 501(c)(3) organizations under contract with them, and intercountry adoption programs. Violations carry fines up to $50,000 or 5 years in prison for individuals, and $100,000 for organizations per offense.
